Dr. Carr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1783 Troup Hwy
Tyler, TX 75701Phone+1 903-595-2283Fax+1 903-595-1063
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1991 - 1994
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1988 - 1991
- David Geffen School of Medicine at UCLAClass of 1988
Certifications & Licensure
- CA State Medical License 1989 - Present
- TX State Medical License 1994 - 2026
- National Board of Physicians and Surgeons Cardiovascular Disease
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Super Doctor SuperDoctors.com
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis Start of enrollment: 2011 Jun 01
- AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN Start of enrollment: 2013 Dec 01
- OEIS Outcome Data Registry Start of enrollment: 2017 Feb 01
Roles: Contact
Publications & Presentations
PubMed
- 907 citationsBivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: ...A. Michael Lincoff, John A. Bittl, Robert A. Harrington, Frederick Feit, Neal S. Kleiman
JAMA. 2003-02-19 - 310 citationsLong-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary rev...A. Michael Lincoff, Neal S. Kleiman, Dean J. Kereiakes, Frederick Feit, John A. Bittl
JAMA. 2004-08-11 - 17 citationsPreliminary Results of the Outpatient Endovascular and Interventional Society National RegistrySamuel S. Ahn, Robert W. Tahara, Lauren E Jones, Jeffrey G Carr, John Blebea
Journal of Endovascular Therapy. 2020-08-19
Press Mentions
- Journalism That Holds Power to AccountMay 24th, 2023
- Rex Medical Receives 510k Clearance for Revolution™ Peripheral Atherectomy SystemSeptember 13th, 2019
- You Don’t Want to Test Positive for THIS in Your 30sAugust 31st, 2017
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Outpatient Endovascular and Interventional SocietyMember
- American Venous and Lymphatic SocietyMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: